Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02127814 · ClinicalTrials.gov registry record · NA
Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT02127814 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 73 participants.
The verdict
NCT02127814, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to find whether Lactobacillus reuteri prevents antibiotic-associated diarrhea and related Clostridium difficile infections. Subjects will be admitted from the University Hospitals Case Medical Center. They will be randomly assigned to an intervention group receiving L. reuteri or a placebo. Supplementation will occur during antibiotic treatment and for an additional 7 days after cessation of treatment. Data collection will occur at baseline, end of antibiotic use, 7 days after antibiotic cessation, and 21 days after antibiotic cessation. Primary data includes diarrhea instances. Secondary data includes severity of diarrhea, presence of C. difficile toxins, and presence of other GI symptoms.
Interventions
- DIETARY_SUPPLEMENT Lactobacillus reuteri
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2010-05 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02127814
The ClinicalTrials.gov registry entry for NCT02127814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus reuteri is the first listed.
NCT02127814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02127814 about?
NCT02127814 is a clinical study titled "Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile". The purpose of this study is to find whether Lactobacillus reuteri prevents antibiotic-associated diarrhea and related Clostridium difficile infections. Subjects will be admitted from the University Hospitals Case Medical Center. They will be randomly assigned to an intervention group receiving L. r...
What is the current status of trial NCT02127814?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2010-05. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT02127814?
The interventions under investigation include: Lactobacillus reuteri (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02127814?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.